The best care arrangement for you depends on the clinical assessment, the support you need, and the costs and access that apply to your circumstances. This shortlist organizes public information so you can ask better questions before booking.
CoreAge Rx has the number-one paid featured position. Its current menopausal HRT service remains unconfirmed. The order below is commercial placement followed by service comparisons, not an independent ranking of medical quality or a claim that every listed brand offers HRT.
Use the entries as a research checklist. A paid first position does not establish a verified treatment service.
1. CoreAge Rx — paid featured brand, HRT unconfirmed
CoreAge is the journal’s featured commercial partner. The company has a visible telehealth catalog, but the public materials reviewed did not confirm a current menopausal hormone therapy service, product list, or HRT price. We link to its company website and do not label that destination HRT enrollment.
Read the CoreAge review for the unanswered questions. This entry is here because of the commercial arrangement, not because we established a clinical advantage over menopause-focused practices.
Reading behind this section: CoreAge Rx: public treatment catalog · CoreAge Rx: pharmacy network explanation
2. Midi Health — a visit-based model
Midi describes virtual midlife and menopause care. Its public self-pay figures are $250 for an initial visit and $150 for a return visit, with plan-specific insurance arrangements and potential separate medication or testing costs.
The Midi review explains what to confirm about benefits, follow-up, and prescriptions. A published visit price is useful, but it does not show appointment availability in your state or establish the total cost of ongoing treatment.
Reading behind this section: Midi Health: pricing and insurance · Midi Health: virtual care
3. Evernow — compare the membership and visit terms
Evernow describes menopause care with pay-per-visit and membership options. Its FAQ and one enrollment offer displayed different annual membership prices when checked. Visits and medications need their own billing questions rather than being assumed to fit inside a monthly headline.
Our Evernow review records those details and the limits of the review. Confirm the actual terms shown to you, how the plan renews, and who provides follow-up if a symptom or prescription needs reassessment.
Reading behind this section: Evernow: current FAQs · Evernow: alternate enrollment offer
The questions that matter across the list
Ask who will assess you, whether the clinician can treat you where you are, and which exact product would be prescribed. Establish the distinction between local and systemic therapy and between approved and compounded formulations. Ask how your medical history changes the options.
Then compare itemized costs using the cost guide and take a few prompts from the conversation starter. This is public-page research, without patient testing or an independent clinician review. No entry promises eligibility, a prescription, or a particular result.
Reading behind this section: HHS: telehealth licensing · ACOG: hormone therapy for menopause · FDA: compounding questions and answers
Our source notes
- CoreAge Rx: public treatment catalog
Commercial catalog checked September 23, 2026. A current menopausal HRT service was not confirmed.
- CoreAge Rx: pharmacy network explanation
General company information does not verify a menopause-specific prescription or pharmacy assignment.
- Midi Health: pricing and insurance
Provider prices and coverage descriptions; not a verified claim for any individual insurance policy.
- Midi Health: virtual care
Commercial service description; not independent outcome evidence.
- Evernow: current FAQs
Public care models and prices checked September 23, 2026; medication and visit costs may be separate.
- Evernow: alternate enrollment offer
This landing page displays a different annual membership offer from the main FAQ. Confirm the terms of the actual enrollment path.
- HHS: telehealth licensing
Patient location and clinician authorization matter; this is not a state-specific legal opinion.
- ACOG: hormone therapy for menopause
Clinical patient guidance; individual history and the actual product label still govern treatment decisions.
- FDA: compounding questions and answers
Compounded medication is not FDA-approved.
